Early Control of H5N1 Influenza Virus Replication by the Type I Interferon Response in Mice
暂无分享,去创建一个
Y. Matsuoka | Hualan Chen | T. Tumpey | S. Sambhara | Kristy J. Szretter | J. Belser | H. Zeng | D. Swayne | Shivaprakash Gangappa | J. Katz
[1] John Steel,et al. Influenza A Virus Strains Differ in Sensitivity to the Antiviral Action of Mx-GTPase , 2008, Journal of Virology.
[2] Guohua Deng,et al. A Single-Amino-Acid Substitution in the NS1 Protein Changes the Pathogenicity of H5N1 Avian Influenza Viruses in Mice , 2007, Journal of Virology.
[3] N. Cox,et al. Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice. , 2007, Virus research.
[4] G. Kochs,et al. The Mx1 Gene Protects Mice against the Pandemic 1918 and Highly Lethal Human H5N1 Influenza Viruses , 2007, Journal of Virology.
[5] R. Krug,et al. The H5N1 Influenza Virus NS Genes Selected after 1998 Enhance Virus Replication in Mammalian Cells , 2007, Journal of Virology.
[6] G. Kochs,et al. Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein , 2007, Journal of Virology.
[7] S. Goodbourn,et al. NS1 Proteins of Avian Influenza A Viruses Can Act as Antagonists of the Human Alpha/Beta Interferon Response , 2006, Journal of Virology.
[8] T. Tumpey,et al. Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in Mice , 2006, Journal of Virology.
[9] J. Hoofnagle,et al. Peginterferon and ribavirin for chronic hepatitis C. , 2006, The New England journal of medicine.
[10] Yi Guan,et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.
[11] P. Fisher,et al. Retinoic acid inducible gene-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines. , 2006, Microbes and infection.
[12] J. Tschopp,et al. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. , 2006, Molecular cell.
[13] R. Webby,et al. Influenza virus NS1 protein protects against lymphohematopoietic pathogenesis in an in vivo mouse model. , 2006, Virology.
[14] S. Goodbourn,et al. Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. , 2006, Virology.
[15] R. Webster,et al. The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04 , 2006, The Journal of experimental medicine.
[16] P. Österlund,et al. TNF-α and IFN-α enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells , 2006 .
[17] R. Webster,et al. Molecular Basis of Replication of Duck H5N1 Influenza Viruses in a Mammalian Mouse Model , 2005, Journal of Virology.
[18] N. Cox,et al. Avian Influenza (H5N1) Viruses Isolated from Humans in Asia in 2004 Exhibit Increased Virulence in Mammals , 2005, Journal of Virology.
[19] B. Stevenson,et al. Current Protocols in Microbiology , 2005 .
[20] R. Webster,et al. Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. , 2005, The Journal of general virology.
[21] S. Dowell,et al. Human Disease from Influenza A (H5N1), Thailand, 2004 , 2005, Emerging infectious diseases.
[22] R. Webster,et al. The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses. , 2004, Virus research.
[23] Shizuo Akira,et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.
[24] Constance Schultsz,et al. Avian influenza A (H5N1) in 10 patients in Vietnam. , 2004, The New England journal of medicine.
[25] Yoshihiro Kawaoka,et al. PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. , 2004, Virology.
[26] J. Peiris,et al. Re-emergence of fatal human influenza A subtype H5N1 disease , 2004, The Lancet.
[27] P. Klenerman,et al. The influence of macrophage inflammatory protein‐1α on protective immunity mediated by antiviral cytotoxic T cells , 2003, Immunology.
[28] R. Krug,et al. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS. , 2003, Virology.
[29] Thorsten Wolff,et al. The Influenza A Virus NS1 Protein Inhibits Activation of Jun N-Terminal Kinase and AP-1 Transcription Factors , 2002, Journal of Virology.
[30] J. Darnell,et al. Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.
[31] R. Webster,et al. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses , 2002, Nature Medicine.
[32] Y. Guan,et al. Molecular changes associated with the transmission of avian influenza a H5N1 and H9N2 viruses to humans * , 2002, Journal of medical virology.
[33] Marc Dalod,et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology , 2001, Nature Immunology.
[34] M. Shaw,et al. Molecular correlates of influenza A H5N1 virus pathogenesis in mice. , 2001, Journal of virology.
[35] Yoshihiro Kawaoka,et al. Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses , 2001, Science.
[36] W. Barclay,et al. Sequences in Influenza A Virus PB2 Protein That Determine Productive Infection for an Avian Influenza Virus in Mouse and Human Cell Lines , 2001, Journal of Virology.
[37] P. Massin,et al. Residue 627 of PB2 Is a Determinant of Cold Sensitivity in RNA Replication of Avian Influenza Viruses , 2001, Journal of Virology.
[38] Amer A. Beg,et al. Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta Interferon , 2000, Journal of Virology.
[39] I. Julkunen,et al. Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages. , 2000, Virology.
[40] T. Tumpey,et al. Depletion of Lymphocytes and Diminished Cytokine Production in Mice Infected with a Highly Virulent Influenza A (H5N1) Virus Isolated from Humans , 2000, Journal of Virology.
[41] K. Akakura,et al. Laparoscopic adrenalectomy for functioning adrenal tumors: clinical experiences with 38 cases and comparison with open adrenalectomy. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[42] K. Omoe,et al. Evolutionary characterization of the six internal genes of H5N1 human influenza A virus. , 2000, The Journal of general virology.
[43] T. Tumpey,et al. Pathogenesis of and immunity to avian influenza A H5 viruses. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[44] N. Cox,et al. A Mouse Model for the Evaluation of Pathogenesis and Immunity to Influenza A (H5N1) Viruses Isolated from Humans , 1999, Journal of Virology.
[45] R. Krug,et al. Influenza A virus NS1 protein targetspoly(A)‐binding protein II of the cellular 3′‐end processing machinery , 1999, The EMBO journal.
[46] H. Goto,et al. Biological Heterogeneity, Including Systemic Replication in Mice, of H5N1 Influenza A Virus Isolates from Humans in Hong Kong , 1999, Journal of Virology.
[47] D. Levy,et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. , 1998, Virology.
[48] R. Webster,et al. Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice. , 1998, The Journal of infectious diseases.
[49] A. García-Sastre,et al. The Role of Interferon in Influenza Virus Tissue Tropism , 1998, Journal of Virology.
[50] M. Katze,et al. Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[51] M. Peiris,et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus , 1998, The Lancet.
[52] F. Hayden,et al. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. , 1998, The Journal of clinical investigation.
[53] D. Gemsa,et al. Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response , 1997, Journal of leukocyte biology.
[54] R. Krug,et al. The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses. , 1996, Virology.
[55] C. Samuel,et al. Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons. , 1995, Virology.
[56] M Aguet,et al. Functional role of type I and type II interferons in antiviral defense. , 1994, Science.
[57] B. Murphy,et al. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range , 1993, Journal of virology.
[58] Robert H. Silverman,et al. Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action , 1993, Cell.
[59] H. Gendelman,et al. Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120 , 1992, Journal of virology.
[60] R. Kumar,et al. Cloning, sequencing, and expression of two murine 2'-5'-oligoadenylate synthetases. Structure-function relationships. , 1991, The Journal of biological chemistry.
[61] I. Kerr,et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.
[62] R. Friedman,et al. Interferon induces the production of membrane protein-deficient and infectivity-defective vesicular stomatitis virions through interference in the virion assembly process. , 1983, The Journal of general virology.
[63] N. Roberts,et al. Virus-induced interferon production by human macrophages. , 1979, Journal of immunology.
[64] M. Peiris. Pathogenesis of avian flu H5N1 and SARS. , 2006, Novartis Foundation symposium.
[65] K. Melén,et al. TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. , 2006, Virology.
[66] S. Baron,et al. Interferon inhibits C-type virus at a posttranscriptional, prerelease step , 2005, Archives of Virology.
[67] Cases of influenza A (H5N1)--Thailand, 2004. , 2004, MMWR. Morbidity and mortality weekly report.
[68] L. Ratner,et al. Alpha Interferon Inhibits Human T-Cell Leukemia Virus Type 1 Assembly by Preventing Gag Interaction with Rafts , 2003 .
[69] Subrata,et al. Cloning , Sequencing , and Expression of Two Murine 2 ’-5 ’-Oligoadenylate Synthetases , 2001 .
[70] M. Caron,et al. Structure-Function Relationships , 1991 .
[71] O. Haller,et al. Interferon-induced Mx protein: a mediator of cellular resistance to influenza virus. , 1987, Interferon.
[72] Y. H. Wu,et al. Antiretroviral effect of interferon: proposed mechanism. , 1982, Journal of interferon research.